Free Trial

Vanguard Personalized Indexing Management LLC Buys 3,061 Shares of Camtek Ltd. $CAMT

Camtek logo with Computer and Technology background

Key Points

  • Vanguard Personalized Indexing Management LLC increased its stake in Camtek Ltd. by 58.7%, owning a total of 8,273 shares valued at approximately $700,000.
  • A number of analysts have recently set new price targets for Camtek, with Needham & Company estimating a target of $98.00 and Bank of America raising theirs to $135.00, reflecting confidence in the stock.
  • Camtek reported earnings of $0.79 EPS for the last quarter, meeting the consensus estimate, with revenues of $123.32 million, marking a 20.2% year-over-year increase.
  • Five stocks to consider instead of Camtek.

Vanguard Personalized Indexing Management LLC raised its stake in Camtek Ltd. (NASDAQ:CAMT - Free Report) by 58.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,273 shares of the semiconductor company's stock after acquiring an additional 3,061 shares during the period. Vanguard Personalized Indexing Management LLC's holdings in Camtek were worth $700,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of CAMT. Clal Insurance Enterprises Holdings Ltd grew its position in shares of Camtek by 27.8% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,134,671 shares of the semiconductor company's stock valued at $123,622,000 after purchasing an additional 464,671 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its holdings in Camtek by 27.6% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,448,441 shares of the semiconductor company's stock valued at $84,922,000 after buying an additional 312,988 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Camtek by 110.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,015,307 shares of the semiconductor company's stock worth $59,527,000 after acquiring an additional 532,944 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Camtek by 1.9% during the 1st quarter. Vanguard Group Inc. now owns 1,002,302 shares of the semiconductor company's stock worth $58,715,000 after acquiring an additional 18,316 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. boosted its position in shares of Camtek by 1.7% during the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 980,074 shares of the semiconductor company's stock valued at $57,462,000 after acquiring an additional 16,200 shares during the last quarter. Hedge funds and other institutional investors own 41.93% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on CAMT. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Camtek in a research note on Wednesday, October 8th. Needham & Company LLC increased their price target on shares of Camtek from $80.00 to $98.00 and gave the company a "buy" rating in a report on Tuesday, August 5th. Jefferies Financial Group set a $105.00 price target on Camtek and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Bank of America upgraded Camtek from a "neutral" rating to a "buy" rating and upped their price objective for the company from $95.00 to $135.00 in a research report on Monday, October 13th. Finally, Cantor Fitzgerald set a $80.00 target price on Camtek and gave the stock a "neutral" rating in a report on Tuesday, June 24th. Nine analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $110.30.

View Our Latest Research Report on CAMT

Camtek Trading Up 1.8%

Shares of NASDAQ CAMT opened at $122.89 on Tuesday. Camtek Ltd. has a fifty-two week low of $47.41 and a fifty-two week high of $127.08. The company has a debt-to-equity ratio of 0.32, a quick ratio of 4.38 and a current ratio of 5.41. The company has a market cap of $5.60 billion, a price-to-earnings ratio of 45.01, a PEG ratio of 3.05 and a beta of 1.39. The business's 50 day moving average price is $96.61 and its 200-day moving average price is $82.73.

Camtek (NASDAQ:CAMT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.79 EPS for the quarter, meeting the consensus estimate of $0.79. Camtek had a return on equity of 23.95% and a net margin of 28.36%.The company had revenue of $123.32 million for the quarter, compared to the consensus estimate of $121.57 million. During the same quarter in the prior year, the company posted $0.66 EPS. Camtek's quarterly revenue was up 20.2% on a year-over-year basis. Camtek has set its Q3 2025 guidance at EPS. On average, sell-side analysts expect that Camtek Ltd. will post 2.93 earnings per share for the current year.

Camtek Company Profile

(Free Report)

Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for semiconductor industry. The company provides Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to address the challenges fanout wafer level packaging applications.

Read More

Want to see what other hedge funds are holding CAMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Camtek Ltd. (NASDAQ:CAMT - Free Report).

Institutional Ownership by Quarter for Camtek (NASDAQ:CAMT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Camtek Right Now?

Before you consider Camtek, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Camtek wasn't on the list.

While Camtek currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.